The effect of bactericidal UV-C treatments (254 nm) on Escherichia coli O157:H7 suspended in apple juice increased synergistically with temperature up to a threshold value. The optimum UV-C treatment temperature was 55uC, yielding a 58.9% synergistic lethal effect. Under these treatment conditions, the UV-heat (UV-H 55uC ) lethal variability achieving 5-log reductions had a logistic distribution (a~37.92, b~1.10). Using this distribution, UV-H 55uC doses to achieve the required juice safety goal with 95, 99, and 99.9% confidence were 41.17, 42.97, and 46.00 J/ml, respectively, i.e., doses higher than the 37.58 J/ml estimated by a deterministic procedure. The public health impact of these results is that the larger UV-H 55uC dose required for achieving 5-log reductions with 95, 99, and 99.9% confidence would reduce the probability of hemolytic uremic syndrome in children by 76.3, 88.6, and 96.9%, respectively. This study illustrates the importance of including the effect of data variability when selecting operational parameters for novel and conventional preservation processes to achieve high food safety standards with the desired confidence level.
Historically the inherent acidity of fruit juices, use of refrigeration, and the addition of chemical preservatives have been assumed to be sufficient to ensure the microbial safety of these products. However, Escherichia coli O157:H7 was identified in the early 1980s as the causative agent of hemorrhagic colitis with hemolytic uremic syndrome (HUS) in children consuming unpasteurized apple juice (48) . The frequency of E. coli O157:H7 infection outbreaks reported among consumers of unpasteurized contaminated apple juice increased over the next two decades (58) . In response, the U.S. Food and Drug Administration (FDA) required juice manufacturers to develop hazard analysis critical control point plans and institute decontamination treatments to achieve 5-log reductions of target pathogens or add a warning label on containers of unpasteurized juice (55) . Although the pathogens of concern differ depending on the juice product and process, E. coli O157:H7, Salmonella enterica, and Cryptosporidium parvum were proposed as targets (4, 56, 58) .
Heat treatments are the most common method used to inactivate microorganisms and enzymes and thus achieve microbial safety and extended shelf life. However, new nonthermal technologies have been developed because consumers prefer minimally processed foods with fresh characteristics (1). Short-wave UV (UV-C) treatment is one of the most promising approaches, especially for fruit juice pasteurization, because it can inactivate a broad range of spoilage and pathogenic microorganisms with minor quality changes and it uses less energy than do other nonthermal techniques (26, 27) . In 2000, the FDA approved the use of UV treatments as an alternative to the thermal pasteurization of fresh juice products (54) . Despite the advantages of UV treatment, its use by the juice industry remains limited. The high concentration of color compounds and suspended solids of juices reduces the penetration depth of UV radiation, which makes it difficult to achieve a significant reduction in microbial load (30) . To overcome this limitation, several strategies have been proposed, including combined treatments based on UV radiation and milder forms of conventional or novel alternative technologies (6, 41, 52) . In recent studies, the combination of simultaneous UV radiation with heat treatment at moderate temperatures (UV-H treatments) increased E. coli inactivation synergistically (21) (22) (23) .
Typically, preservation technologies are assessed by deterministic methods to estimate whether a given set of process conditions can meet a specified food safety goal. Ignoring the variability of the process lethality can lead to over-or underprocessing, compromising food safety or product stability (46) . Consequently, regulatory agencies have begun to require a specified and high level of certainty that food safety goals are being met (57, 59) . Thus, the statistical distribution of the parameters involved in the predictive models describing quantitatively the microbial inactivation kinetics must be known (7, 34, 46) . Several authors have described UV microbial inactivation as a multihit process because of the presence of shoulders, tails, or both in the survival curves, proposing the use of nonlinear models to describe UV inactivation kinetics (39, 44, 53) . Although the thermodependence of UV inactivation between 40.0 and 60.0uC has been characterized (22, 23) , the variability of the lethality of combined UV-H treatments on the most significant pathogens affecting public health has not been evaluated.
Quantitative microbial risk assessment (QMRA) can be used to assess a particular pathogen risk by following its fate along the food chain. QMRA is associated with the emerging application of food safety metrics linking food safety management practices with improvements in public health (50) . Public health goals are defined on the basis of an appropriate level of protection defined as an achievable risk reduction that is economically feasible and socially tolerable or acceptable (60) . Food safety objectives (FSOs) are then defined as the maximum consumer tolerable frequency and/or microbial hazard food present at consumption (29) . Performance objectives then define the FSO that must be accomplished at specific steps in the food chain, and performance criteria define the change in pathogen frequency and/or level to be achieved by specific processing steps or control measures (29) .
This study was conducted to illustrate the advantages of using stochastic procedures when assessing the microbial lethality of new nonthermal processes to establish appropriate operational parameters for meeting food safety standards with the desired high probability for all production lots. This objective was addressed by designing a combined UV-H treatment for the inactivation of E. coli O157:H7 in apple juice meeting the FDA microbial safety requirement. To illustrate the impact of the designed UV-H treatment on public health, a QMRA model was developed to estimate the incidence frequency of HUS in a given population consuming contaminated apple juice. Because of the high susceptibility of children to E. coli O157:H7 infection (16, 51) , the two groups chosen were children 2 to 5 and 5 to 10 years old. The probabilistic procedure yielded process recommendations that differ depending on the confidence level specified.
MATERIALS AND METHODS
Bacterial culture. Verotoxigenic E. coli O157:H7 phage type 34 strain (5) was used in this investigation. The bacterial culture was kept at 280uC in cryovials. Stationary-phase cultures were prepared by inoculating 10 ml of tryptone soy broth (Biolife, Milan, Italy) supplemented with 0.6% (wt/vol) yeast extract (Biolife) (TSBYE) with a loopful of cells harvested from a culture grown on tryptone soy agar (Biolife) supplemented with 0.6% (wt/ vol) yeast extract (TSAYE). The cultures were incubated at 35uC for 6 h in a shaking incubator (Vibramax 100, Heidolph Instruments, Scwabach, Germany). Culture aliquots (50 ml) were inoculated into 50 ml of fresh TSBYE and incubated for 24 h under the same conditions, which resulted in stationary-phase cultures containing approximately 2 | 10 9 CFU/ml. UV treatments. UV treatments were carried out as previously described by Gayán et al. (21) in a unit with eight individual annular thin-film flow-through reactors connected in series and equipped with a feed tank and a peristaltic pump (ISM 10785, Ismatec, Glattbrugg, Switzerland). Each reactor included a low-pressure mercury vapor lamp (8 W input power; model TUV 8WT5, Philips Electronics, Amsterdam, The Netherlands), which converted 30% of the input power as UV-C radiation (43) and emitting 85% of UV-C energy at 254 nm. The lamp was attached to the axis of an outer glass tube (25 mm inside diameter) and enclosed by a quartz tube (20 mm outside diameter) to prevent direct contact between the lamp and the treatment medium (21) . The mean irradiance on the quartz surface was 13.4 mW/cm 2 (UVX-25 sensors, UVP, Inc., Upland, CA). In the annular gap (2.5 mm), a stainless steel coil spring (outside and inside coil diameters of 23 and 25 mm, respectively; length and pitch of 270 and 10 mm, respectively) was installed to improve the turbulence of the flow. A manual sampling valve was situated in the outlet of each reactor. The entire unit was submerged in a 90-liter water bath (25.0 to 62.5uC) heated by the circulating water of a peripheral thermostatic bath (Kattebad K12, Huber, Offenburg, Germany). Thermocouples (ZA 020-FS, Almeco, Bernburg, Germany) fitted to the inlet and outlet of the first and last reactor, respectively, allowed treatment temperature control.
Apple juice (García Carrion, Madrid, Spain) used for the treatment medium (absorption coefficient, 25.54 cm 21 ; turbidity, 3.34 NTU; pH 3.27) was purchased locally (Zaragoza, Spain). The absorption coefficient of juice was measured spectrophotometrically (254 nm; UV500, Unicam Ltd., Cambridge, UK). Samples were diluted and evaluated using quartz cuvettes (Hellma, Müllheim, Germany) with path lengths of 1, 2, and 10 mm. The absorption coefficient of the diluted samples was determined from the slope of the absorbance versus the path length and corrected by the dilution factor. Turbidity was measured with a nephelometer (HI 83749, Hanna Instrument, Szeged, Hungary), and pH was measured with a pH meter (Basic 20, Crison Instruments, Barcelona, Spain). Apple juice was inoculated with the E. coli O157:H7 culture to achieve 1 to 5 | 10 7 CFU/ml and pumped at 8.5 liters/h through the heat exchanger and UV reactors. When the flow rate stabilized at its preset value, samples were withdrawn through the sampling valves at the outlet of each reactor, and 0.1 or 1 ml was immediately pour plated on the recovery medium.
Heat treatments. Heat treatments were carried out in a specially designed resistometer as described by Condón et al. (10) . This device consists of a 350-ml vessel provided with an electrical heater, an agitation device to ensure inoculum distribution and temperature homogeneity of the treatment medium, and ports to inject the microbial suspension and remove samples. Upon temperature stabilization to preset values (56.6, 58.6, 60.6, 62.6, and 64.6 ¡ 0.05uC), 0.2 ml of an adequately diluted microbial cell suspension (,5 | 10 8 CFU/ml) was inoculated into the treatment medium. After inoculation, 0.2-ml samples were collected at different heating times and immediately pour plated.
Incubation of treated samples and counts of surviving cells. TSAYE plates were used as the recovery medium and incubated for 24 h at 35uC. Preliminary tests revealed that longer incubation times did not change the profiles of the survival curves. After incubation, colonies were counted with an improved colony counter (Image Analyzer Automatic Colony Counter, Protos, Synoptics, Cambridge, UK) as described elsewhere (11) .
Kinetics of microbial inactivation. E. coli O157:H7 inactivation was quantified as the logarithm of the surviving fraction as a function of treatment dose (d) expressed in joules per milliliter and time (t) expressed in minutes for UV-H and thermal treatments, respectively. The UV dose was calculated as electrical energy consumption to compare the energetic efficiency of these treatments with those of other technologies (26) . Following this approach, the applied dose was calculated by dividing the total input power of UV lamps by the flow rate, because the theoretical retention time of reactors was close to that determined experimentally from the residence time distribution of different volume fractions (21) . Microbial resistance parameters were determined using the Geeraerd et al. inactivation model-fitting tool (GInaFiT) (25) . Because survival curves for UV and heat treatments had shoulders but no tails, the log-linear regression plus shoulder model of Geeraerd et al. (24) was selected:
where N 0 is the initial count, N d is the number of survivors, and d is the UV-H treatment dose applied. This model describes the survival curves through two parameters: the shoulder length (Sl), defined as the dose or time before the exponential inactivation begins, and the inactivation rate (K max ), defined as the slope of the exponential portion of the survival curve. GInaFiT also provides the 4D parameter, identified as the treatment dose or time need to inactivate 99.99% of the microbial population, which was used to compare treatments. All microbial resistance determinations were performed at least three times on different experimental days. The error bars in the figures correspond to the mean standard deviation.
UV-H treatment optimization. The synergistic lethal effect of the combination UV-H treatments was quantified by comparing experimental 4D UV-H values provided by the GInaFiT software with the corresponding theoretical values (theoretical 4D UV-H ), both expressed as process time, as previously proposed Gayán et al. (22) . Theoretical 4D UV-H values represent the time needed to achieve a 99.99% reduction in the microbial population when the two processes act simultaneously but independently with additive but no synergistic lethal effects. These values were calculated as
where 4D H , and 4D UV values were obtained from thermal and UV inactivation treatments, respectively. The magnitude of the synergistic lethal effect for each temperature was expressed as
The temperature at which UV-H treatments had the maximum percent synergism was considered the optimum combined process treatment temperature. Once the UV-H treatment temperature was optimized, kinetic parameters of several survival curves obtained under this condition (20 experimental runs) were analyzed to assess the distribution of the treatment dose required for achieving the 5-log reductions required by the FDA (55).
QMRA model. The QMRA model used followed the risk assessment paradigm described by the Codex Alimentarius Commission (8, 9) with the data summarized in Table 1 . Because of the lack of information on the contamination level of E. coli O157:H7 in freshly pressed apple juice, a hypothetical value for the initial microbial level was assumed. Considering a daily juice consumption of 100 ml, the Fresh Produce Subcommittee of the National Advisory Committee on Microbiological Criteria for Foods (NACMCF) estimated that a tolerable risk level for processed juice consumption requires validated processes that achieve a cumulative 5-log reduction of the target pathogen or a reduction in yearly risk of illness to less than 10 25 (37) . Applying FSOs and related concepts to juice decontamination, the NACMCF indicated that the FSO for enteric pathogens should be ,1 CFU/ 10 liters (38) . During storage under acidic environmental conditions, the target pathogens do not grow but often die off (14, 42) ; thus, the performance objective after pasteurization was considered equal to the FSO. Consequently, E. coli O157:H7 contamination of the freshly pressed apple juice before pasteurization must not exceed 10 CFU/ml.
After considering the lethality of UV-H treatments for the E. coli O157:H7 population in apple juice, the ingested dose (i) was calculated by integrating the remaining E. coli O157:H7 contamination at consumption time and the apple juice volume ingested per serving (V). The daily apple juice consumption for 2through 10-year-old children was calculated from data obtained from the 1999 through 2002 U.S. National Health and Nutrition Examination Survey (40) . The percentage of participants consuming fruit juices was 43%, among which the mean daily intake for age groups of 2 to 3, 4 to 8, and 9 to 11 years was 177.4 ¡ 18.6, 103.5 ¡ 11.8, and 106.5 ¡ 8.6 ml, respectively. Juice consumption and child age were assumed to follow normal and uniform distributions, respectively ( Table 1) .
The exponential single-hit dose-response model developed by Delignette-Muller et al. (12) was used to estimate the probability of developing HUS (P HUS ) after consuming juice contaminated with a given E. coli O157:H7 level (equation 4). The single-hit model assumes that only one ingested pathogen cell is required to cause infection, that the number of cells ingested follows a Poisson distribution, and that each pathogen cell has an equal and independent probability of causing infection in the host calculated from a binomial distribution (28, 49) . The exponential model for the ingestion dose i, the simplest form of single-hit models, has been used extensively to describe the dose-response in risk assessments (19, 35) :
where r, the only model parameter and assumed to follow normal distributions, is defined as the probability of developing HUS after ingestion of a single pathogen cell. According to Delignette-Muller et al. (12) , for 5-to 10-year-old children r was 2.4 | 10 24 (95% confidence interval [CI], 9.0 | 10 25 to 5.3 | 10 24 ) and was five times higher for 0-to 5-year-old children (1.2 | 10 23 ; 95% CI, 5.3 | 10 24 to 2.3 | 10 23 ). The risk of developing HUS after consuming UV-H-treated apple juice was expressed as illness probability per serving (P HUS/serving ).
Probabilistic modeling. Each variable in the risk model was assigned random values drawn from probabilistic distributions incorporating the variability and uncertainty of the input data (3). This calculation was repeated (iterations) to obtain a probability distribution for the results reflecting the input data variability. The analysis was carried out with the software @Risk Industrial (version 5.5, Palisade Inc., Newfield, NY) using 10,000 iterations with the Latin hypercube method. The best fit tool in the software was used to obtain the best distribution function using the chisquare statistic as the selecting criterion. The processing dose meeting the 5-log reduction goal was identified using the Goal Seek tool at the 95, 99, and 99.9% confidence levels.
RESULTS
UV-H treatment optimization. Figure 1 shows the effect of temperature on the inactivation of E. coli O157:H7 in commercial apple juice by UV treatments. Some survival curves had an initial lag phase followed by an exponential inactivation rate. Concave downwards survival curves were fitted with the log-linear regression plus shoulder model described by Geeraerd et al. (24) , and the experimental model parameter averages (Sl and K max ) and 4D UV-H values are compiled in Table 2 . The table includes the coefficient of determination (R 2 ) and the root mean square error (RMSE) values obtained from the fit. The maximum dose possible in one pass (27.10 J/ml; pumping the apple juice at 8.5 liters/h through eight reactors) applied at room temperature (25uC) decreased E. coli O157:H7 counts by only 0.65 ¡ 0.02 log CFU/ml ( Fig. 1 ) because of the UV absorption coefficient of apple juice at 25.54 cm 21 . However, simultaneous UV and mild heat treatments between 50.0 and 60.0uC increased the inactivation considerably. A UV treatment of 20.33 J/ml (pumping the apple juice at 8.5 liters/h through six reactors) at 40.0uC increased the inactivation by 0.22 log CFU/ml, whereas UV-H treatments at 50.0, 52.5, 55.0, 57.5, 60.0, and 62.5uC improved the lethality to 0.49, 0.87, 1.44, 2.86, 5.47, and .6 log CFU/ml, respectively (Fig. 1) . The increase of the UV lethal effect was explained by the decrease in Sl and increase in K max with increasing treatment temperature ( Table 2 ). To determine the contribution of thermal effects to the lethality of the UV-H treatments, the heat resistance of E. coli O157:H7 in apple juice was determined experimentally at 56.6, 58.6, 60.6, 62.6, and 64.6uC. Heat survival curves also had a lag period followed by first order kinetics. Resistance parameters were estimated using the survival model previously described (Table 3 ). Similar to the results of the UV-H treatments, the reduction of heat resistance with temperature was reflected in both the increase of the inactivation rate and the decrease of the shoulder phase. The relationship between the logarithm of 4D H parameter and treatment temperature for heat only (TDT curve) revealed the expected linear relationship (log 4D H~2 0.177T z11.30, R 2~0 .987) (Fig. 2) from which a z-value (temperature increase that reduces the 4D H values 10 times) of 5.7uC was obtained (Fig. 2) . In contrast, when plotting the treatment time needed to reach the 99.99% probability of bacterial inactivation by the combined treatment (4D UV-H ) against temperature (UV-TDT curve), a concave downward profile was obtained (Fig. 2) .
To determine whether the improvement in UV lethality at moderate temperatures was due to additive or synergistic effects, theoretical 4D UV-H values for each treatment temperature were calculated assuming that UV and heat act simultaneously but independently (equation 2). The theoretical UV-TDT curve was constructed from theoretical 4D UV-H data and included in Figure 2 (dotted line) for comparison purposes. The range of temperatures at which experimental 4D UV-H values were higher than theoretical values indicates the occurrence of a synergistic lethal effect. The area between theoretical and experimental UV-TDT curves indicates the dependency of the synergy on the treatment temperature. The synergistic lethal effect increased with temperature up to a threshold and then decreased up to 62.5uC, the temperature at which the 4D UV-H value almost coincided with the value on the TDT curve (Fig. 2) . To determine the temperature for maximum UV-H synergism, the percent synergistic lethal effect at each temperature was calculated by comparing theoretical and experimental 4D UV-H values (equation 3). The temperature for maximum synergism was 55uC, which corresponds to a synergistic lethal effect of 58.9% (Fig. 3 ).
Risk analysis of UV-H pasteurized apple juice. The optimum synergism temperature (55uC) was used to estimate the UV-H 55uC processing dose achieving a 5-log pathogen reduction calculated following a deterministic and a probabilistic approach. The E. coli O157:H7 inactivation variability of UV-H 55uC treatments was assessed by analyzing 20 replicate experiments in apple juice treated with 54.20 J/ml, the maximum dose achieved with two passes through the reactor system (pumping the apple juice at 8.5 liters/h through 16 reactors), yielding means of 8.86 and 4.01 ml/J for Sl and K max , respectively ( Table 2 ). The dose data distribution was adjusted to a logistic distribution with a~37.92 and b~1.10 for the best function fitted (x 2 0.400) ( Fig. 4 ). Deterministic mean-based calculations achieving 5-log reductions in E. coli O157:H7 yielded a 37.58 J/ml UV-H 55uC dose (Table 2 ). However, when considering sources of variability and uncertainty, the failure probability for this treatment to achieve this FSO would be 48.5% (Fig. 4) . To achieve 5-log reductions with 95, 99, and 99.9% confidence as recommended (57, 59) , the UV-H 55uC treatment would have to increase to 41.17, 42.97, and 46.00 J/ml, respectively.
The public health impact of the UV-H 55uC processing dose arrived at through deterministic and probabilistic approaches with different acceptability levels (95, 99, and 99.9%) was estimated by risk analysis. Published input data (Table 1 ) and the vector of inactivation lethality parameter values describing the UV-H 55uC variability ( Table 2) were coded in the QMRA model to predict the probability of developing HUS in two subpopulations of children consuming apple juice treated at 37.58, 41.17, 42.97, and 46.00 J/ml. The calculation output values, including the probability of developing HUS per serving (mean and 95% CI), are shown in Table 4 . As expected, the E. coli O157:H7 dose ingested per serving was similar for both age groups. However, the log P HUS/serving value was about 84% higher for the 2-to 5-year-olds than for the 5-to 10-year-olds in all treatments, reflecting the higher susceptibility of younger children. For UV-H 55uC treatments calculated by the deterministic procedure (37.58 J/ml), the log P HUS/serving was 25.40 and 26.18 for 2-to 5-year-old and 5-to 10-yearold children, respectively. Increasing the treatment dose to achieve 5-log reductions with 95% (41.17 J/ml), 99% (42.97 J/ml), and 99.9% (46.00 J/ml) certainty reduced the P HUS/serving to 26.02, 26.33, and 26.86 for 2-to 5-year-old children and 26.81, 27.11, and 27.69 for 5-to 10-year-old children, respectively. A plot of the UV-H 55uC dose and the log P HUS/serving values for 2-to 5-year-old and 5-to 10-yearold children yielded a linear relationship with the same slope for both age groups (Fig. 5 ). The 10-fold reduction of the P HUS/serving would require increasing the UV-H 55uC dose by 5.7 J/ml.
DISCUSSION
In this investigation, the inactivation of E. coli O157:H7 in apple juice by UV treatments in a corrugatedtube thin-film flow system was evaluated. Applying the maximum UV dose possible in one pass (27.10 J/ml) at room temperature decreased the E. coli O157:H7 population by only 0.65 ¡ 0.02 log CFU/ml, which is far from the 5log reduction required by the FDA juice production regulation (55) . Several studies have been conducted to determine the lethal efficacy of UV processing on E. coli populations in apple juice using different continuous devices (2, 20, 31, 44, 59) . Nevertheless, comparisons are difficult due to the various conformations and geometries of UV equipment, flow patterns, and optical properties of the liquid used (36) . Findings from published studies indicates that UV radiation may result in significant reduction of microbial pathogens in fruit juices. However, compliance with the FDA requirement solely through the use of UV treatments would be possible only in clarified juice with very low levels of background microflora processed at extremely slow flow rates or with multiple passes, conditions that probably are impractical for use in commercial settings (30, 59) . A solution to this limitation is the use of hurdle approaches combining UV radiation with conventional and alternative nonthermal technologies. The simultaneous application of heat at sublethal temperatures and other nonthermal technologies, such as high hydrostatic pressure, ultrasound, and pulsed electric field, has been thoroughly investigated (45) ; however, few reports of combination treatments of UV radiation and mild heat have been published. The inactivation of E. coli O157:H7 by UV treatment increased slightly when the treatment temperature was increased to 40.0uC. However, the lethality of UV-H treatments between 50.0 and 60.0uC increased significantly, to more than 5 log CFU/ml at temperatures above 57.5uC when applying a treatment of 27.10 J/ml (Fig. 1) . This behavior is reflected in the thermodependency of UV-H treatments, indicated by the concave profile of the UV-TDT curve (Fig. 2) . These results agree with those reported by Ukuku and Geveke (52) , who evaluated a combined treatment of UV radiation and a radio frequency electric field, which increased the temperature to 40uC. The combination increased slightly the UV lethal effect on E. coli in apple juice. Recently, we found that temperatures above 40uC increased the lethality of UV treatment synergistically (21) (22) (23) . In contrast to UV-H treatments, the TDT curve had the expected log-linear relationship with a z-value (5.7uC) in agreement with data reported by Mazzotta (5.6uC) (32) and Enache et al. (4.9 to 5.5uC) (15) for other E. coli O157:H7 serotypes treated in apple juice.
To determine the nature of the lethal effect of the combined treatment, inactivation data were compared with theoretical values assuming than the lethality of heat and UV radiation were additive (Fig. 2) . Differences between these values indicated the occurrence of a synergistic lethal effect, but the magnitude of this discrepancy changed with the treatment temperature. At the optimum temperature the synergism was maximized; above this value, the synergy decreased to zero, indicating that at that temperature the UV-H lethality depended solely on thermal effects. The temperature of maximum synergistic effect was 55uC (58.9% synergistic lethal effect) consistent with the value reported for a UV-tolerant E. coli strain (STCC 4201) previously studied in apple juice (55uC; 38.1% synergistic lethal effect) (23) . Thus, to profit maximally from the synergistic lethal effect of the combination of these technologies, apple juice should be treated by UV radiation at 55uC.
Regulatory agencies have begun to require compliance with food safety goals with a 95% certainty or even higher for life threatening hazards such as E. coli O157:H7 (57, 61) . The variability of the inactivation kinetics of E. coli O157:H7 treated by UV-H 55uC was assessed in this study. A logistic distribution (a~37.92 and b~1.10) for the treatment dose needed to achieve a 5-log reduction was obtained ( Fig. 4) . Inactivation kinetics parameters are often assumed to follow a normal distribution, but normal-like distributions are only rarely observed and thus care must be taken when choosing a statistical distribution (13, 47) . Alternative and commonly used distributions such as beta, logistic, and exponential distributions can describe better the variability and uncertainty of the data (13, 17, 18, 47) , and this approach was followed in this study. From the obtained logistic distribution, we estimated that the doses necessary to inactivate a 5-log reduction of E. coli O157:H7 by UV-H 55uC treatment with 95, 99, and 99.9% confidence (41.17, 42 .97, and 46.00 J/ml, respectively) were 9.1, 12.6, and 18.3% higher than that the dose calculated by a deterministic procedure (37.58 J/ml). In other words, the UV-H 55uC process criteria estimated by a probabilistic approach would have a 5, 1, and 0.1% chance of failing to comply with the juice safety goal, whereas using a deterministic calculation, the probability of failure would be 48.5%.
Subsequently, the impact on public health of establishing process criteria by both probabilistic and deterministic procedures was evaluated for the risk of developing HUS in children 2 to 5 and 5 to 10 years consuming apple juice treated by UV-H 55uC . For both groups, the log P HUS/serving was related linearly with the applied treatment dose and was 84% higher in younger population than in the older group (Fig. 5 ). The P HUS/serving decreased by 76.3, 88.3, and 96.9% when complying with the 5-log reduction goal with 95, 99, and 99.9% confidence compared with using mean value calculations.
Food safety goals based on a minimum number of log reductions of a target pathogen, as is the current juice safety standard imposed by the FDA, are commonly used in food FIGURE 5 . Relationship between log P HUS/serving for 2-to 5-yearold and 5-to 10-year-old children and the UV-H 55uC dose that achieved 5-log reductions of E. coli O157:H7in apple juice as estimated by a deterministic procedure and a probabilistic approach with 95, 99, and 99.9% certainty.
risk management when pathogen load data are not available (34) . These performance criteria are somewhat arbitrary and are often based on worst-case scenarios (33) . The results of this QMRA study are specific to the experimental equipment used and are based on unrealistic scenarios and thus have no authoritative value. This study illustrates the importance of including the variability and uncertainty of inactivation kinetics data when designing preservation processes and the use of risk assessment to optimize process criteria. For instance, a 10-fold reduction in the probability of developing HUS by children consuming apple juice treated with UV-H 55uC would require increasing the treatment dose by 5.7 J/ml.
